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FRACTION OF TWENTY PERCENT OR LESS" 
Andrew S. Wechsler, MD 
K aul and his coauthors [see page 1001] relate their experience with a group of patients having low 
ejection fractions on whom they performed coro- 
nary artery bypass grafting. Careful statistics docu- 
ment early and late survival, expressed as hazard 
probabilities. On the basis of these results, the 
authors attribute nhanced success to the use of a 
combination of antegrade and retrograde cardiople- 
gia, performing fewer bypass grafts (shorter cross- 
clamp times), and the absence of preoperative ven- 
tricular arrhythmias as a primary indication for 
operation. The patients in their study had complex 
problems and had several different indications for 
operations. Simultaneous and independent events 
may have influenced outcome, independent of the 
factors identified. These include experience, change 
in operative technique, inadvertent changes in op- 
erative selection, and other factors that constitute 
risks inherent in all retrospective studies. As such, it 
is uncertain whether similar modifications in oper- 
ative technique by other groups are likely to yield 
the same results. Nonetheless, this study stimulated 
me to think about operations on patients with low 
ejection fractions and to reexamine the issues inher- 
ent in such a designation and study focus. 
Why focus on results in patients with low ejection 
fractions? Presumably, the answer is determined 
from studies indicating the high risk of operation 
juxtaposed against the poor outcomes in patients 
treated medically. To some extent, surgeons weigh 
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their technical expertise by survival in patients in 
whom the risk is high, are challenged by high risk, 
and are appropriately proud of good results. A low 
ejection fraction is generally assumed to be a surro- 
gate for a bad heart. But is it really? Many patients 
with low ejection fractions have been observed for 
years with remarkably good functional capacity. 
Other patients with comparably low ejection frac- 
tions require intensive diuretic therapy and after- 
load reduction. Some patients are so profoundly ill 
that cardiac transplantation appears to be the only 
hope for survival. 
The anatomic diagnosis of a "bad ventricle" is 
difficult. It may be quantitated as ejection fraction, 
summated reductions in chord length shortening, 
ventricular dilatation, or a ventricle that is poorly 
contracting on angiographic or radionuclide study. 
Bad ventricles are better defined by their functional 
capacity. Are symptoms of congestive heart failure 
present? What is the maximum oxygen consumption 
under conditions of stress? What are the pharma- 
cologic requirements of the patient o achieve rea- 
sonably comfortable day-to-day activities? How high 
are the filling pressures and how low is the cardiac 
index? Given such a complex of parameters that 
describe ventricular quality, it is not surprising that 
ejection fraction alone is a poor predictor of mor- 
tality in any given patient. Perhaps this is borne out 
in the Parsonnet scoring system and in the database 
of the Society of Thoracic Surgeons. Predictors of 
risk at the highest level consistently overestimate he 
actual risk (observed/expected <1). Kaul and his 
colleagues wisely selected patients presumed to po- 
tentially benefit from operation. A requirement for 
inclusion in their operative program was that the 
patient have evidence of reversible ischemia. This 
served as an "improvable lement" in the constella- 
tion of risk predictors in patients with low ejection 
fraction but otherwise undefinable risk predictors. 
Enhanced understanding of the factors that deter- 
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mine poor long-term outcome and good or bad surgi- 
cal outcome is important. The number of hearts 
available for transplantation relative to the number of 
patients recommended for transplantation is diminish- 
ing. The medical management of congestive heart 
failure is improving. The historic quote of 5-year 
survivals of 20% to 30% is no longer accurate. The 
survival of patients referred but not receiving cardiac 
transplantation in the early Stanford heart transplan- 
tation experience was only about 10% after 6 months 
to I year. Such is not the case in contemporary cardiac 
transplantation programs. Patients who do not receive 
urgent ransplantation r surgical intervention shortly 
after recommendation f rtransplantation have a 3- to 
4-year survival that parallels that of patients uccess- 
fully undergoing transplantation. 1 Recent studies have 
shown that with careful selection, subsets of patients 
referred for cardiac transplantation may undergo re- 
vascularization a d have survivals that match those of 
patients having transplantation. 2-4 What is lacking is a 
predictive scoring system that takes into account most 
of the parameters critical as descriptors of left ventric- 
ular performance. Ideally, this would include ischemic 
risk, end-diastolic volume, end-systolic volume, filling 
pressures, ejection fraction, cardiac index, and maxi- 
mal oxygen consumption. I have not seen a large series 
that has used logistic regression analysis incorporating 
all of these parameters todetermine which parameters 
constitute the most critical elements of operative risk 
or that combined parameters mathematically to evolve 
a risk score based on the important interactions be- 
tween these critical risk elements. 
Current techniques for assessing the success of 
operations focus on factors prevalent in patients with 
good outcomes. Similarly, factors that may have been 
responsible for bad outcomes are identified by statis- 
tical analysis of multiple parameters but rarely by 
evaluating exquisite details of individual operations. 
Such is the nature of contemporary mathematical 
inquiry, and great advances have occurred as a conse- 
quence of this approach. On the other hand, there may 
be some room for applying the technique of "failure 
analysis" in a highly reasoned fashion. This may ap- 
pear, at first, to be a step backward. It de-mathema- 
tizes the process to make it feel more like one that 
occurs every week in most institutions at the surgical 
quality assurance conferences (also known as morbid- 
ity and mortality conferences). In such settings, a bad 
result is justified by quoting a predicted risk. That 
having been done, the events of the operation respon- 
sible for a less favorable outcome are reviewed as if the 
operation were an isolated event. The Federal Avia- 
tion Administration does not determine factors asso- 
ciated with unsuccessful flights by crashing 747s, mod- 
ifying their design, and crashing them again. Instead, 
detailed and painstaking analysis of every air mishap 
contributes to an understanding of factors that may 
produce an adverse outcome. Those factors are incor- 
porated into new aircraft design and the human aspect 
taught o airplane crews. Review of the recent litera- 
ture suggests that coronary artery bypass grafting in 
patients with low ejection fractions is not as high risk 
an environment as one might think. Confounding 
factors frequently play a role in adverse outcomes. Just 
as in aircraft disasters, it is frequently a constellation f
several events "gone wrong" that results in mortality. 
Several studies have reported operations for manage- 
ment of coronary artery disease in patients with bad 
ventricles with mortality of 5% or less. In such an 
environment, does one learn more from the successes 
or from the failures? s-s 
Why do patients with bad ventricles have worse 
survival results after operation than patients with 
good ventricles? Presumably, patients die if revas- 
cularization is incomplete, if there is a mishap 
during the operation, and if myocardial protective 
techniques are not excellent. Added to those obvi- 
ous answers is the complex physiology that accom- 
panies bad ventricles. Virtually all ventricles with 
low ejection fractions have undergone some degree 
of remodeling. Myocytes are exposed to abnormal 
stresses and hormonal stimulation, and they express 
alterations in phenotype. Regions of myocardium 
are thinned, scarred, dilated, and are accompanied 
by other regions of myocardium that are hypertro- 
phied. Flow imbalances at the microcirculatory level 
exist. The high catecholamine environment of car- 
diopulmonary bypass, fluctuations in perfusion, un- 
even reperfusion, variable myocardial protection, 
and imbalances in loading conditions after cardio- 
pulmonary bypass probably contribute to dysfunc- 
tion. This is an area still ripe for new investigation. 
Critical dissection of poor outcomes hould occur 
even in the presence of the traditional crepe that may 
be hung before such operations. With an aged popu- 
lation and more patients urviving acute myocardial 
infarction, it is highly likely that the population of 
patients with bad ventricles will increase, and the 
mandate to increase operative success clearly exists. 
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